Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
作者信息
Ring J, Worm M, Wollenberg A, Thyssen J P, Jakob T, Klimek L, Bangert C, Barbarot S, Bieber T, de Bruin-Weller M S, Chernyshov P V, Christen-Zaech S, Cork M, Darsow U, Flohr C, Fölster-Holst R, Gelmetti C, Gieler U, Gutermuth J, Heratizadeh A, Hijnen D J, von Kobyletzki L B, Kunz B, Paul C, De Raeve L, Seneschal J, Simon D, Spuls P I, Stalder J F, Svensson A, Szalai Z, Taieb A, Torrelo A, Trzeciak M, Vestergaard C, Werfel T, Weidinger S, Deleuran M
机构信息
Department Dermatology Allergy Biederstein, Technical University Munich, Munich, Germany.
Divison Allergy and Immunology, Department of Dermatology and Allergology, Charité University Hospital, Berlin, Germany.
出版信息
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.
Abstract
摘要
相似文献
1
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.过敏性皮肤病患者接种新型冠状病毒肺炎疫苗后发生严重过敏反应的风险——实用建议。欧洲皮肤科和性病学会与外部专家的立场声明
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.
2
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.ARIA-EAACI 关于 COVID-19 疫苗严重过敏反应的声明——一份 EAACI-ARIA 立场文件。
Allergy. 2021 Jun;76(6):1624-1628. doi: 10.1111/all.14726.
3
[Not Available].[无可用内容]
Laryngorhinootologie. 2021 May;100(5):344-354. doi: 10.1055/a-1397-0754. Epub 2021 Mar 8.
4
[MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].[严重过敏反应的管理、诊断和治疗，包括对新冠疫苗的过敏反应]
Arerugi. 2021;70(3):215-223. doi: 10.15036/arerugi.70.215.
5
Management of patients at risk of anaphylaxis after COVID 19 vaccination.COVID-19 疫苗接种后发生过敏反应风险患者的管理。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):843-846. doi: 10.23812/21-20-E.
6
Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective.新冠疫苗接种后的过敏反应——正确看待风险
JAMA Netw Open. 2021 Aug 2;4(8):e2122326. doi: 10.1001/jamanetworkopen.2021.22326.
7
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.一种评估接种BNT162b2疫苗患者过敏风险的合理算法的疗效。
Vaccine. 2021 Oct 22;39(44):6464-6469. doi: 10.1016/j.vaccine.2021.09.048. Epub 2021 Sep 28.
8
Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.特应性皮炎患者的 COVID-19 疫苗：皮肤科医生应该知道的三件事。
Acta Dermatovenerol Alp Pannonica Adriat. 2021 Jun;30(2):67-69.
9
[COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].[新冠病毒疫苗：疫苗靶点、免疫原性及过敏反应]
Rev Med Suisse. 2021 Apr 7;17(733):690-696.
10
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
引用本文的文献
1
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes.确定催乳素信号通路与新冠疫苗诱导的月经变化之间的因果联系。
NPJ Vaccines. 2023 Sep 1;8(1):129. doi: 10.1038/s41541-023-00719-6.
2
Stroke seven hours after SARS-CoV-2 vaccination.新型冠状病毒2019冠状病毒病疫苗接种后7小时发生中风。
Clinics (Sao Paulo). 2023 Apr 10;78:100193. doi: 10.1016/j.clinsp.2023.100193. eCollection 2023.
3
Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study.新型冠状病毒肺炎（SARS-CoV-2）疫苗接种对接受度普利尤单抗治疗的特应性皮炎患者的影响：一项多中心观察性研究。
Ann Dermatol. 2023 Feb;35(1):38-45. doi: 10.5021/ad.22.118.
4
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.住院皮肤科医生需了解的新型冠状病毒2型感染与疫苗接种的皮肤表现
Curr Dermatol Rep. 2022;11(4):252-262. doi: 10.1007/s13671-022-00374-5. Epub 2022 Oct 19.
5
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.一项关于 COVID-19 疫苗接种后黏膜皮肤表现的系统评价和关于重要免疫介导性皮肤病疫苗接种的专家建议。
Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11.
6
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines.与SARS-CoV-2疫苗相关的皮肤不良反应
J Clin Med. 2021 Nov 16;10(22):5344. doi: 10.3390/jcm10225344.
7
Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.新型冠状病毒疫苗接种引起的皮肤和过敏反应：综述。
J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.
8
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.新型冠状病毒肺炎疫苗的皮肤不良反应：免疫皮肤病学视角的见解
Vaccines (Basel). 2021 Aug 25;9(9):944. doi: 10.3390/vaccines9090944.
9
SARS-CoV-2 Vaccines and the Skin.严重急性呼吸综合征冠状病毒2型疫苗与皮肤
Actas Dermosifiliogr. 2021 Oct;112(9):828-836. doi: 10.1016/j.adengl.2021.07.028. Epub 2021 Aug 28.
10
Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.与 COVID-19 疫苗接种相关的皮肤和过敏反应——一篇叙述性综述。
Wien Med Wochenschr. 2022 Mar;172(3-4):63-69. doi: 10.1007/s10354-021-00876-0. Epub 2021 Aug 23.
本文引用的文献
1
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.欧洲特应性皮炎工作组：关于正在接受全身用药和生物制剂治疗的成年特应性皮炎患者接种新冠病毒（SARS-CoV-2）疫苗的立场。
J Eur Acad Dermatol Venereol. 2021 May;35(5):e308-e311. doi: 10.1111/jdv.17167. Epub 2021 Mar 7.
3
[Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].[新冠病毒-19疫苗接种与过敏反应风险——实际管理建议]
MMW Fortschr Med. 2021 Jan;163(1):48-51. doi: 10.1007/s15006-021-9530-6.
4
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
5
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.ARIA-EAACI 关于 COVID-19 疫苗严重过敏反应的声明——一份 EAACI-ARIA 立场文件。
Allergy. 2021 Jun;76(6):1624-1628. doi: 10.1111/all.14726.
6
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
7
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
8
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.欧洲皮肤病与性病学会/欧洲变态反应与临床免疫学会湿疹工作组2020年关于成人和儿童特应性皮炎诊断与治疗的立场文件。
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2717-2744. doi: 10.1111/jdv.16892. Epub 2020 Nov 17.
9
International Consensus (ICON): allergic reactions to vaccines.国际共识（ICON）：疫苗过敏反应
World Allergy Organ J. 2016 Sep 16;9(1):32. doi: 10.1186/s40413-016-0120-5. eCollection 2016.
Zotero 插件